IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

NCT00202878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

18144

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Myocardial Infarction

Interventions

DRUG: ezetimibe/simvastatin
DRUG: simvastatin
DRUG: Placebo for simvastatin 40 mg
DRUG: Placebo for ezetimibe 10 mg/simvastatin 40 mg combination

Sponsor

Organon and Co